OnCo

Stay in the loop

Leave your email and OnCo will write when something big changes in cancer research. No spam, one click to unsubscribe.

Email updates open shortly. Until then, press Watch on any page to keep it on your list.

Cancers & treatments·Sequencing

Lung cancer (all types): lines of therapy

Cancer page →

3 standard-of-care settings across 2 lines and 1 biomarker subgroup. Rows come from the cancer page's standard of care; the grid places each on its line and subgroup.

LineAll comers
Screening, prevention and diagnosis2
Other settings1

Screening, prevention and diagnosis

SubgroupSettingApproachProducts and trialsEvidence
All comersScreeningAnnual low-dose CT for people aged about 50 to 80 with a heavy smoking history (NLST, NELSON).
NLST & NELSON (low-dose CT screening)
83
All comersDiagnosis and stagingCT, PET-CT, bronchoscopy or CT-guided biopsy, endobronchial ultrasound of nodes, brain MRI; molecular testing on every non-squamous non-small-cell tumour.
Non-small-cell lung cancerPET (positron emission tomography)
66

Other settings

SubgroupSettingApproachProducts and trialsEvidence
All comersTreatmentBy type and stage on the subtype pages: surgery or stereotactic radiotherapy for early disease, chemoradiation with immunotherapy for locally advanced, targeted or immune therapy for metastatic disease.
Non-small-cell lung cancerSmall-cell lung cancerSBRT / SABR (stereotactic radiotherapy)
40

Lines and subgroups are parsed from the setting text of each standard-of-care row and can misclassify an unusual phrasing; the row’s own setting is always shown. Guideline chips reflect the NCCN category and ESMO-MCBS grade recorded on the cancer page, checked on its stated date. Not medical advice.